Connect Biopharma is trading 5.3% up at $2.18 today, extending its recent upside momentum amid a broad risk-on sentiment and a rally across biotech names.
- The advance follows a strong close in the previous session and aligns with gains in the XBI biotech ETF and major market indices.
- No new company-specific catalysts have been reported this morning, suggesting the move is driven by macro factors and sector-wide strength.